{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T16:33:16Z","timestamp":1773160396162,"version":"3.50.1"},"reference-count":104,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["dldjournalonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.dld.2017.01.164","type":"journal-article","created":{"date-parts":[[2017,2,2]],"date-time":"2017-02-02T15:16:37Z","timestamp":1486048597000},"page":"595-603","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Rifaximin and diverticular disease: Position paper of the Italian Society of Gastroenterology (SIGE)"],"prefix":"10.1016","volume":"49","author":[{"given":"Rosario","family":"Cuomo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Barbara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9120-5957","authenticated-orcid":false,"given":"Bruno","family":"Annibale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2017.01.164_bib0005","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1038\/ajg.2012.194","article-title":"Diverticular disease as a chronic illness evolving epidemiologic and clinical insights","volume":"107","author":"Strate","year":"2012","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2017.01.164_bib0010","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1111\/j.1572-0241.1999.01501.x","article-title":"Diagnosis and management of diverticular disease of the colon in adults: ad hoc practice parameters committee of the American college of gastroenterology","volume":"94","author":"Stollman","year":"1999","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2017.01.164_bib0015","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1177\/2050640614547068","article-title":"Italian consensus conference for colonic diverticulosis and diverticular disease","volume":"5","author":"Cuomo","year":"2014","journal-title":"United European Gastroenterology Journal"},{"key":"10.1016\/j.dld.2017.01.164_bib0020","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10151-015-1370-x","article-title":"Italian Society of Colon and Rectal Surgery. Practice parameters for the treatment of colonic diverticular disease: Italian Society of Colon and Rectal Surgery (SICCR) guidelines","volume":"10","author":"Binda","year":"2015","journal-title":"Techniques in Coloproctology"},{"key":"10.1016\/j.dld.2017.01.164_bib0025","first-page":"C4453","article-title":"Danish guidelines for treatment of diverticular disease","volume":"59","author":"Andersen","year":"2012","journal-title":"Danish Medical Journal"},{"key":"10.1016\/j.dld.2017.01.164_bib0030","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1515\/pjs-2015-0045","article-title":"Polish interdisciplinary consensus on diagnostics and treatment of colonic diverticulosis","volume":"87","author":"Pietrzak","year":"2015","journal-title":"Polski Przeglad Chirurgiczny"},{"key":"10.1016\/j.dld.2017.01.164_bib0035","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1053\/j.gastro.2015.10.001","article-title":"American gastroenterological association institute technical review on the management of acute diverticulitis","volume":"149","author":"Strate","year":"2015","journal-title":"Gastroenterology"},{"issue":"Suppl. 1","key":"10.1016\/j.dld.2017.01.164_bib0040","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000089779","article-title":"Colonic diverticular disease: pathophysiology and clinical picture","volume":"73","author":"Parra-Blanco","year":"2006","journal-title":"Digestion"},{"key":"10.1016\/j.dld.2017.01.164_bib0045","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1053\/gast.2002.32978","article-title":"The burden of selected digestive diseases in the United States","volume":"122","author":"Sandler","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2017.01.164_bib0050","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1365-2036.2009.04098.x","article-title":"Diverticular disease hospital admissions are increasing, with poor outcomes in the elderly and emergency admissions","volume":"30","author":"Jeyarajah","year":"2009","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1016\/j.dld.2017.01.164_bib0055","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.cgh.2013.06.020","article-title":"Long-term risk of acute diverticulitis among patients with incidental diverticulosis found during colonoscopy","volume":"12","author":"Shahedi","year":"2013","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2017.01.164_bib0060","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0140-6736(04)15597-9","article-title":"Diverticular disease of the colon","volume":"363","author":"Stollman","year":"2004","journal-title":"The Lancet"},{"key":"10.1016\/j.dld.2017.01.164_bib0065","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00384-011-1314-5","article-title":"Review of current classifications for diverticular disease and a translation into clinical practice","volume":"27","author":"Klarenbeek","year":"2012","journal-title":"International Journal of Colorectal Disease"},{"key":"10.1016\/j.dld.2017.01.164_bib0070","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/ajg.2009.621","article-title":"Diarrhea-predominant irritable bowel syndrome is associated with diverticular disease: a population-based study","volume":"105","author":"Jung","year":"2010","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2017.01.164_bib0075","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1007\/s10350-007-0226-5","article-title":"Prospective, five-year follow-up study of patients with symptomatic uncomplicated diverticular disease","volume":"50","author":"Salemi","year":"2007","journal-title":"Diseases of the Colon and Rectum"},{"key":"10.1016\/j.dld.2017.01.164_bib0080","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1097\/MCG.0b013e318188b1bc","article-title":"Symptom severity and disease acitivity indices for diverticulitis","volume":"42","author":"Floch","year":"2008","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1016\/j.dld.2017.01.164_bib0085","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1046\/j.1463-1318.2003.00458.x","article-title":"Diverticular disease has an impact on quality of life-results of a preliminary study","volume":"5","author":"Bolster","year":"2003","journal-title":"Colorectal Disease"},{"key":"10.1016\/j.dld.2017.01.164_bib0090","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000103896","article-title":"Quality of life in uncomplicated symptomatic diverticular disease: is it another good reason for treatment?","volume":"25","author":"Comparato","year":"2007","journal-title":"Digestive Diseases"},{"key":"10.1016\/j.dld.2017.01.164_bib0095","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1097\/MCG.0000000000000633","article-title":"Diverticular disease and IBS: overlapping or misunderstanding","volume":"50","author":"Spiller","year":"2016","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1016\/j.dld.2017.01.164_bib0100","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2016-312377","article-title":"Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease","author":"Barbara","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.dld.2017.01.164_bib0105","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/MCG.0000000000000094","article-title":"Moderate to severe and prolonged left lower-abdominal pain is the best symptom characterizing symptomatic uncomplicated diverticular disease of the colon: a comparison with fecal calprotectin in clinical setting","volume":"49","author":"Tursi","year":"2015","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1016\/j.dld.2017.01.164_bib0110","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.cgh.2013.03.007","article-title":"Increased risk for irritable bowel syndrome after acute diverticulitis","volume":"12","author":"Cohen","year":"2013","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2017.01.164_bib0115","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1053\/j.gastro.2009.02.074","article-title":"Postinfectious irritable bowel syndrome","volume":"136","author":"Spiller","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2017.01.164_bib0120","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/nmo.12526","article-title":"Changing views on diverticular disease: impact of aging, obesity, diet, and microbiota","volume":"27","author":"Spiller","year":"2015","journal-title":"Neurogastroenterology and Motility"},{"key":"10.1016\/j.dld.2017.01.164_bib0125","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1097\/00042737-200309000-00011","article-title":"Patterns of pain in diverticular disease and the influence of acute diverticulitis","volume":"15","author":"Simpson","year":"2003","journal-title":"European Journal of Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2017.01.164_bib0130","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1007\/BF02234460","article-title":"Twenty-four hour recordings of colonic motility in patients with diverticular disease: evidence for abnormal motility and propulsive activity","volume":"44","author":"Bassotti","year":"2001","journal-title":"Diseases of the Colon and Rectum"},{"key":"10.1016\/j.dld.2017.01.164_bib0135","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1136\/gut.2003.018093","article-title":"Colorectal visceral perception in diverticular diesase","volume":"53","author":"Clemens","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.dld.2017.01.164_bib0140","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00384-012-1488-5","article-title":"Clinical features of symptomatic uncomplicated diverticular disease: a multicenter Italian survey","volume":"27","author":"Annibale","year":"2012","journal-title":"International Journal of Colorectal Disease"},{"key":"10.1016\/j.dld.2017.01.164_bib0145","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/eci.12152","article-title":"Symptom patterns can distinguish diverticular disease from irritable bowel syndrome","volume":"43","author":"Cuomo","year":"2013","journal-title":"European Journal of Clinical Investigation"},{"key":"10.1016\/j.dld.2017.01.164_bib0150","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s10350-004-0853-z","article-title":"Long-term outcome of mesocolic and pelvic diverticular abscesses of the left colon: a prospective study of 73 cases","volume":"48","author":"Ambrosetti","year":"2005","journal-title":"Diseases of the Colon and Rectum"},{"key":"10.1016\/j.dld.2017.01.164_bib0155","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/archsurg.140.7.681","article-title":"Risk of emergency colectomy and colostomy in patients with diverticular disease","volume":"140","author":"Anaya","year":"2005","journal-title":"Archives of Surgery"},{"key":"10.1016\/j.dld.2017.01.164_bib0160","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1001\/archsurg.140.6.576","article-title":"Hospitalization for acute diverticulitis does not mandate routine elective colectomy","volume":"140","author":"Broderick-Villa","year":"2005","journal-title":"Archives of Surgery"},{"key":"10.1016\/j.dld.2017.01.164_bib0165","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/DCR.0b013e3182028576","article-title":"Long-term followup after an initial episode of diverticulitis: what are the predictors of recurrence","volume":"54","author":"Hall","year":"2011","journal-title":"Diseases of the Colon and Rectum"},{"key":"10.1016\/j.dld.2017.01.164_bib0170","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/SLA.0b013e3181952888","article-title":"Diverticulitis in the United States: 1998\u20132005: changing patterns of disease and treatment","volume":"249","author":"Etzioni","year":"2009","journal-title":"Annals of Surgery"},{"key":"10.1016\/j.dld.2017.01.164_bib0175","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1046\/j.1365-2036.2003.01551.x","article-title":"Diverticular disease of the colon\u2014on the rise: a study of hospital admissions in England between 1989\/1990 and 1999\/2000","volume":"17","author":"Kang","year":"2003","journal-title":"Alimentary Pharmacology Therapeutics"},{"key":"10.1016\/j.dld.2017.01.164_bib0180","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1097\/SLA.0000000000001114","article-title":"Long-term outcomes after initial presentation of diverticulitis","volume":"262","author":"Rose","year":"2015","journal-title":"Annals of Surgery"},{"key":"10.1016\/j.dld.2017.01.164_bib0185","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/bjs.7035","article-title":"Patterns of recurrence in patients with acute diverticulitis","volume":"97","author":"Eglinton","year":"2010","journal-title":"British Journal of Surgery"},{"key":"10.1016\/j.dld.2017.01.164_bib0190","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/bjs.9119","article-title":"Assessment of recurrence and complications following uncomplicated diverticulitis","volume":"100","author":"Buchs","year":"2013","journal-title":"British Journal of Surgery"},{"key":"10.1016\/j.dld.2017.01.164_bib0195","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1517\/14656566.2011.546347","article-title":"Biologic properties and clinical uses of rifaximin","volume":"12","author":"Herbert","year":"2011","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"10.1016\/j.dld.2017.01.164_bib0200","first-page":"51","article-title":"Pharmacokinetic study of rifaximin after oral administration in healthy volunteers","volume":"14","author":"Descombe","year":"1994","journal-title":"International Journal of Clinical Pharmacology Research"},{"key":"10.1016\/j.dld.2017.01.164_bib0205","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0005-2787(67)90147-5","article-title":"The specific inhibition of the DNA-directed RNA synthesis by rifamycin","volume":"145","author":"Hartmann","year":"1967","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.dld.2017.01.164_bib0210","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ijantimicag.2009.11.013","article-title":"Rifaximin-induced alteration of virulence of diarrhoea-producing Escherichia coli and Shigella sonnei","volume":"35","author":"Jiang","year":"2010","journal-title":"International Journal of Antimicrobial Agents"},{"key":"10.1016\/j.dld.2017.01.164_bib0215","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1128\/AAC.45.1.212-216.2001","article-title":"In vitro antimicrobial susceptibility testing of bacterial enteropathogens causing traveler\u2019s diarrhea in four geographic regions","volume":"45","author":"Gomi","year":"2001","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.dld.2017.01.164_bib0220","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1128\/AAC.45.2.643-644.2001","article-title":"In vitro activity of rifaximin against enteropathogens producing traveler\u2019s diarrhea","volume":"45","author":"Sierra","year":"2001","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.dld.2017.01.164_bib0225","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1128\/AAC.01623-06","article-title":"In vitro activities of 15 antimicrobial agents against 110 toxigenic clostridium difficile clinical isolates collected from 1983 to 2004","volume":"51","author":"Hecht","year":"2007","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.dld.2017.01.164_bib0230","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1007\/s10620-013-2675-0","article-title":"The effect of rifaximin on gut flora and Staphylococcus resistance","volume":"58","author":"Kim","year":"2013","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1016\/j.dld.2017.01.164_bib0235","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1093\/jac\/dkq345","article-title":"Rifaximin modulates the colonic microbiota of patients with Crohn\u2019s disease: an in vitro approach using a continuous culture colonic model system","volume":"65","author":"Maccaferri","year":"2010","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.dld.2017.01.164_bib0240","doi-asserted-by":"crossref","first-page":"e60042","DOI":"10.1371\/journal.pone.0060042","article-title":"Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy","volume":"8","author":"Bajaj","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.dld.2017.01.164_bib0245","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/ja.2014.106","article-title":"Rifaximin: beyond the traditional antibiotic activity","volume":"67","author":"Calanni","year":"2014","journal-title":"Journal of Antibiotics"},{"key":"10.1016\/j.dld.2017.01.164_bib0250","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000443361","article-title":"The role of antibiotics in gut microbiota modulation: the eubiotic effects of rifaximin","volume":"34","author":"Ponziani","year":"2016","journal-title":"Digestive Diseases"},{"key":"10.1016\/j.dld.2017.01.164_bib0255","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1128\/AAC.00691-09","article-title":"Pretreatment of epithelial cells with rifaximin alters bacterial attachment and internalization profiles","volume":"54","author":"Brown","year":"2010","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.dld.2017.01.164_bib0260","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1124\/jpet.107.121913","article-title":"Rifaximin is a gut-specific human pregnane X receptor activator","volume":"322","author":"Ma","year":"2007","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.dld.2017.01.164_bib0265","first-page":"120","article-title":"Rifaximin improves Clostridium difficile toxin A-induced toxicity in Caco-2 cells by the PXR-dependent TLR4\/MyD88\/NF-\u03baB pathway","volume":"9","author":"Esposito","year":"2016","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.dld.2017.01.164_bib0270","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.tips.2012.03.003","article-title":"Pregnane X receptor as a target for treatment of inflammatory bowel disorders","volume":"33","author":"Cheng","year":"2012","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.dld.2017.01.164_bib0275","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejps.2014.01.007","article-title":"Pregnane X receptor agonists enhance intestinal epithelial wound healing and repair of the intestinal barrier following the induction of experimental colitis","volume":"55","author":"Terc","year":"2014","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.dld.2017.01.164_bib0280","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1053\/j.gastro.2005.12.008","article-title":"The pregnane X receptor locus is associated with susceptibility to inflammatory bowel disease","volume":"130","author":"Dring","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2017.01.164_bib0285","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1128\/AAC.44.8.2205-2206.2000","article-title":"In vitro activity and fecal concentration of rifaximin after oral administration","volume":"44","author":"Jiang","year":"2000","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.dld.2017.01.164_bib0290","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1128\/AAC.00161-10","article-title":"Bile acids improve the antimicrobial effect of rifaximin","volume":"54","author":"Darkoh","year":"2010","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.dld.2017.01.164_bib0295","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1053\/j.gastro.2013.10.026","article-title":"Rifaximin alters intestinal bacteria and prevents stress-induced gut inflammation and visceral hyperalgesia in rats","volume":"146","author":"Xu","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2017.01.164_bib0300","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2165\/00003495-199549030-00009","article-title":"Rifaximin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential in conditions mediated by gastrointestinal bacteria","volume":"49","author":"Gillis","year":"1995","journal-title":"Drugs"},{"key":"10.1016\/j.dld.2017.01.164_bib0305","first-page":"979","article-title":"Rapid disappearance from the intestinal tract of bacteria resistant to Rifaximin","volume":"XII","author":"De Leo","year":"1986","journal-title":"Drugs under Experimental and Clinical Research"},{"key":"10.1016\/j.dld.2017.01.164_bib0310","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1179\/joc.2002.14.3.290","article-title":"Effects of rifaximin administration on the intestinal microbiota in patients with ulcerative colitis","volume":"14","author":"Brigidi","year":"2002","journal-title":"Journal of Chemotherapy"},{"key":"10.1016\/j.dld.2017.01.164_bib0315","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3748\/wjg.v13.i2.264","article-title":"Efficacy of long term cyclic administration of the poorly absorbed antibiotic rifaximin in symptomatic, uncomplicated colonic diverticular disease","volume":"13","author":"Colecchia","year":"2007","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2017.01.164_bib0320","doi-asserted-by":"crossref","first-page":"696812","DOI":"10.1155\/2014\/696812","article-title":"Uncomplicated diverticular disease: innate and adaptive immunity in human gut mucosa before and after rifaximin","volume":"2014","author":"Cianci","year":"2014","journal-title":"Journal of Immunology Research"},{"key":"10.1016\/j.dld.2017.01.164_bib0325","first-page":"452","article-title":"Efficacy of rifaximin on symptoms of uncomplicated diverticular disease of the colon. A pilot multicentre open trial. Diverticular Disease Study Group","volume":"24","author":"Papi","year":"1992","journal-title":"Italian Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2017.01.164_bib0330","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2036.1995.tb00348.x","article-title":"Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double-blind placebo-controlled trial","volume":"9","author":"Papi","year":"1995","journal-title":"Alimentary Pharmacology Therapeutics"},{"key":"10.1016\/j.dld.2017.01.164_bib0335","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00384-002-0396-5","article-title":"Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon","volume":"18","author":"Latella","year":"2003","journal-title":"International Journal of Colorectal Disease"},{"key":"10.1016\/j.dld.2017.01.164_bib0340","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/apt.13434","article-title":"The antimicrobial effects of rifaximin on the gut microbiota","volume":"43","author":"Du Pont","year":"2016","journal-title":"Alimentary Pharmacology Therapeutics"},{"key":"10.1016\/j.dld.2017.01.164_bib0345","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.phrs.2014.05.001","article-title":"Impact of crystal polymorphism on the systemic bioavailability of rifaximin, an antibiotic acting locally in the gastrointestinal tract, in healthy volunteers","volume":"85","author":"Blandizzi","year":"2014","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.dld.2017.01.164_bib0350","doi-asserted-by":"crossref","first-page":"805","DOI":"10.7326\/0003-4819-142-10-200505170-00005","article-title":"A randomized, double-blind, placebo controlled trial of rifaximin to prevent travelers\u2019 diarrhea","volume":"142","author":"DuPont","year":"2005","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.dld.2017.01.164_bib0355","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1086\/323814","article-title":"Rifaximin versus ciprofloxacin for the treatment of traveler\u2019s diarrhea: a randomized, double-blind clinical trial","volume":"33","author":"DuPont","year":"2001","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.dld.2017.01.164_bib0360","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/j.1572-0241.2003.07283.x","article-title":"Therapy of travelers\u2019 diarrhea with rifaximin on various continents","volume":"98","author":"Steffen","year":"2003","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2017.01.164_bib0365","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.4269\/ajtmh.2006.74.1060","article-title":"A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers\u2019 diarrhea","volume":"74","author":"Taylor","year":"2006","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"10.1016\/j.dld.2017.01.164_bib0370","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1159\/000007580","article-title":"Rifaximin: a nonabsorbed antimicrobial in the therapy of travelers\u2019 diarrhea","volume":"59","author":"DuPont","year":"1998","journal-title":"Digestion"},{"key":"10.1016\/j.dld.2017.01.164_bib0375","doi-asserted-by":"crossref","first-page":"557","DOI":"10.7326\/0003-4819-145-8-200610170-00004","article-title":"The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial","volume":"145","author":"Pimentel","year":"2006","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.dld.2017.01.164_bib0380","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1111\/j.1365-2036.2006.02879.x","article-title":"Antibiotic treatment of Crohn\u2019s disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin","volume":"23","author":"Prantera","year":"2006","journal-title":"Alimentary Pharmacology Therapeutics"},{"key":"10.1016\/j.dld.2017.01.164_bib0385","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s10620-006-9442-4","article-title":"Hospitalizations during the use of rifaximin versus lactulose for the treatment of hepatic encephalopathy","volume":"52","author":"Leevy","year":"2007","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1016\/j.dld.2017.01.164_bib0390","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.amjmed.2011.08.026","article-title":"Evaluation of harm in the pharmacotherapy of irritable bowel syndrome","volume":"125","author":"Shah","year":"2012","journal-title":"American Journal of Medicine"},{"key":"10.1016\/j.dld.2017.01.164_bib0395","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1345\/aph.1K675","article-title":"Rifamycin antibiotics for treatment of Clostridium difficile-associated diarrhea","volume":"42","author":"Garey","year":"2008","journal-title":"The Annals of Pharmacotherapy"},{"key":"10.1016\/j.dld.2017.01.164_bib0400","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/MCG.0b013e31814a4e97","article-title":"Rifaximin in treatment of ecurrent clostridium difficile-associated diarrhea: an uncontrolled pilot study","volume":"43","author":"Garey","year":"2009","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1016\/j.dld.2017.01.164_bib0405","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.3748\/wjg.15.2628","article-title":"Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: experience with rifaximin","volume":"15","author":"Peralta","year":"2009","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2017.01.164_bib0410","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1004409","article-title":"Rifaximin therapy for patients with irritable bowel syndrome without constipation","volume":"364","author":"Pimentel","year":"2011","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.dld.2017.01.164_bib0415","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","article-title":"Rifaximin treatment in hepatic encephalopathy","volume":"362","author":"Bass","year":"2010","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.dld.2017.01.164_bib0420","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0168-8278(02)00350-1","article-title":"Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial","volume":"38","author":"Mas","year":"2003","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2017.01.164_bib0425","first-page":"175","article-title":"Rifaximin versus neomycin on hyperammoniemia in chronic portal systemic encephalopathy of cirrhotics. A double-blind, randomized trial","volume":"23","author":"Pedretti","year":"1991","journal-title":"Italian Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2017.01.164_bib0430","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.3748\/wjg.v9.i7.1385","article-title":"Diverticular disease of the colon: new perspectives in symptom development and treatment","volume":"9","author":"Colecchia","year":"2003","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2017.01.164_bib0435","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/j.1365-2036.2011.04606.x","article-title":"Meta-analysis: long-term therapy with rifaximin in the management of uncomplicated diverticular disease","volume":"33","author":"Bianchi","year":"2011","journal-title":"Alimentary Pharmacology Therapeutics"},{"key":"10.1016\/j.dld.2017.01.164_bib0440","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1097\/DCR.0b013e318223cb2b","article-title":"Treatment of diverticular disease of the colon and prevention of acute diverticulitis: a systematic review","volume":"54","author":"Maconi","year":"2011","journal-title":"Diseases of the Colon and Rectum"},{"key":"10.1016\/j.dld.2017.01.164_bib0445","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1111\/j.1572-0241.2008.01879.x","article-title":"Diverticular disease and diverticulitis","volume":"103","author":"Sheth","year":"2008","journal-title":"American Journal of Gastroenterology"},{"issue":"Suppl. 1","key":"10.1016\/j.dld.2017.01.164_bib0450","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1097\/MCG.0000000000000580","article-title":"The management of patients with diverticulosis and diverticular disease in primary care: an online survey among Italian general pratictioners","volume":"50","author":"De Bastiani","year":"2016","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1016\/j.dld.2017.01.164_bib0455","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00508-013-0447-7","article-title":"Non-interventional study evaluating efficacy and tolerability of rifaximin for treatment of uncomplicated diverticular disease","volume":"126","author":"Stallinger","year":"2014","journal-title":"Wiener Klinische Wochenschrift"},{"key":"10.1016\/j.dld.2017.01.164_bib0460","article-title":"Colonic diverticular disease","volume":"2011","author":"Humes","year":"2011","journal-title":"BMJ Clin Evid."},{"key":"10.1016\/j.dld.2017.01.164_bib0465","first-page":"295","article-title":"Cyclic antibiotic therapy for diverticular disease: a critical reappraisal","volume":"19","author":"Zullo","year":"2010","journal-title":"Journal of Gastrointestinal and Liver Diseases"},{"key":"10.1016\/j.dld.2017.01.164_bib0470","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S1590-8658(02)80110-4","article-title":"Long-term treatment with mesalazine and rifaximin versus rifaximin alone for patients with recurrent attacks of acute diverticulitis of colon","volume":"34","author":"Tursi","year":"2002","journal-title":"Digestive and Liver Disease"},{"key":"10.1016\/j.dld.2017.01.164_bib0475","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.dld.2012.09.006","article-title":"One year intermittent rifaximin plus fibre supplementation vs. fibre supplementation alone to prevent diverticulitis recurrence: a proof-of-concept study","volume":"45","author":"Lanas","year":"2013","journal-title":"Digestive and Liver Disease"},{"key":"10.1016\/j.dld.2017.01.164_bib0480","first-page":"342","article-title":"Effectiveness of different therapeutic strategies in preventing diverticulitis recurrence","volume":"17","author":"Tursi","year":"2013","journal-title":"European Review for Medical and Pharmacological Sciences"},{"key":"10.1016\/j.dld.2017.01.164_bib0485","doi-asserted-by":"crossref","first-page":"S332","DOI":"10.1016\/S0016-5085(15)31104-5","article-title":"Modifying the clinical history of recurrent diverticulitis: a pragmatic trial with mesalazine (M) or rifaximin (R)","volume":"148","author":"Festa","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2017.01.164_bib0490","first-page":"CD009092","article-title":"Antibiotics for uncomplicated diverticulitis","volume":"11","author":"Wille-Jorgensen","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.dld.2017.01.164_bib0495","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/jama.2013.282025","article-title":"Sigmoid diverticulitis: a systematic review","volume":"311","author":"Morris","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.dld.2017.01.164_bib0500","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s00384-012-1486-7","article-title":"Systematic review of medical therapy to prevent recurrent diverticulitis","volume":"27","author":"Unl\u00fc","year":"2012","journal-title":"International Journal of Colorectal Disease"},{"key":"10.1016\/j.dld.2017.01.164_bib0505","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/bjs.8688","article-title":"AVOD study group randomized clinical trial of antibiotics in acute uncomplicated diverticulitis","volume":"99","author":"Chabok","year":"2012","journal-title":"British Journal of Surgery"},{"key":"10.1016\/j.dld.2017.01.164_bib0510","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/bjs.10309","article-title":"Dutch Diverticular Disease (3D) Collaborative Study Group. Randomized clinical trial of observational versus antibiotic treatment for a first episode of CT-proven uncomplicated acute diverticulitis","volume":"104","author":"Daniels","year":"2017","journal-title":"Br J Surg."},{"key":"10.1016\/j.dld.2017.01.164_bib0515","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/eb-2012-100762","article-title":"Antibiotics may not improve short-term or long-term utcomes in acute uncomplicated diverticulitis","volume":"18","author":"Westwood","year":"2013","journal-title":"Evidence-Based Medicine"},{"key":"10.1016\/j.dld.2017.01.164_bib0520","series-title":"The evolving threat of antimicrobial resistance: options for action","author":"World Health Organization","year":"2012"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865817301925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865817301925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T06:48:55Z","timestamp":1719038935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865817301925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":104,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S1590865817301925"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2017.01.164","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rifaximin and diverticular disease: Position paper of the Italian Society of Gastroenterology (SIGE)","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2017.01.164","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}